Gross negligence of states in monitoring fake and substandard medicines
The ambitious digital initiative launched by the Central Government to strengthen the monitoring of fake, substandard and non-standard medicines in the pharmaceutical market, which is directly related to the health of crores of citizens of the country, is not getting the expected momentum due to the apathy and negligence of the states. According to the … Read more